A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Virology

• Publication date

  2010-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01512-10PMID 20980506PMCID PMC3014199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice.

  2010cited by this paper
• AP-1 homolog BZLF1 of Epstein–Barr virus has two essential functions dependent on the epigenetic state of the viral genome

  2009cited by this paper
• Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

  2009cited by this paper
• Long-Term Administration of Valacyclovir Reduces the Number of Epstein-Barr Virus (EBV)-Infected B Cells but Not the Number of EBV DNA Copies per B Cell in Healthy Volunteers

  2009cited by this paper
• T cell-mediated control of Epstein-Barr virus infection in humanized mice.

  2009cited by this paper
• CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection.

  2008cited by this paper
• The role of TRAIL death receptors in the treatment of hematological malignancies

  2008cited by this paper
• Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells

  2008cited by this paper
• A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses.

  2008cited by this paper
• Current understanding of the role of Epstein–Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas

  2008cited by this paper
• Roles of lytic viral infection and IL‐6 in early versus late passage lymphoblastoid cell lines and EBV‐associated lymphoproliferative disease

  2007cited by this paper
• Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

  2007cited by this paper
• Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

  2006cited by this paper
• Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model

  2005cited by this paper
• Epstein-Barr Virus Lytic Infection Is Required for Efficient Production of the Angiogenesis Factor Vascular Endothelial Growth Factor in Lymphoblastoid Cell Lines

  2005cited by this paper
• EBV the prototypical human tumor virus--just how bad is it?

  2005cited by this paper
• Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.

  2005cited by this paper
• EBV Infection Induces Expression of the Transcription Factors ATF-2/c-Jun in B Lymphocytes but not in B-CLL Cells

  2005cited by this paper
• Experimental Infection of NOD/SCID Mice Reconstituted with Human CD34+ Cells with Epstein-Barr Virus

  2004cited by this paper
• Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma.

  2004cited by this paper
• Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

  2004cited by this paper
• A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene.

  2003cited by this paper
• Senile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients

  2003cited by this paper
• Epstein–Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction

  2003cited by this paper
• Glycoprotein gp110 of Epstein–Barr virus determines viral tropism and efficiency of infection

  2002cited by this paper
• The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators

  2000cited by this paper
• Infection of Primary Human Monocytes by Epstein-Barr Virus

  2000cited by this paper
• CD40‐CD40 ligand

  2000cited by this paper
• Extranodal peripheral T-cell and NK-cell neoplasms.

  1999cited by this paper
• Epstein–Barr virus‐mediated B‐cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

  1998cited by this paper
• Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.

  1998cited by this paper
• High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma.

  1998cited by this paper
• Epstein-Barr virus in Hodgkin's disease.

  1998cited by this paper
• EPSTEIN–BARR VIRUS (EBV) INFECTION IN INFECTIOUS MONONUCLEOSIS: VIRUS LATENCY, REPLICATION AND PHENOTYPE OF EBV‐INFECTED CELLS

  1997cited by this paper
• Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.

  1997cited by this paper
• Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response

  1997cited by this paper
• A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator

  1996cited by this paper
• Epstein-Barr virus and its replication

  1996cited by this paper
• Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.

  1995cited by this paper
• Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1

  1995cited by this paper
• Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.

  1994cited by this paper
• Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus

  1993cited by this paper
• Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.

  1993cited by this paper
• Epstein-Barr virus recombinants with specifically mutated BCRF1 genes

  1993cited by this paper
• Epstein-Barr virus in Hodgkin's disease.

  1991cited by this paper
• Epstein-Barr virus.

  1991cited by this paper
• Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

  1982cited by this paper
• Age-related Ebv-associated B-cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: a Study of 96 Patients Clinical Oncology

  year unknowncited by this paper

• A combination of proviral and antiviral roles of CD11c- and T-bet-expressing B cells defines parameters of chronic murine gammaherpesvirus infection

  2026cites this paper
• A tonsil organoid model reveals Epstein-Barr virus infected germinal center B cell states during primary infection

  2026cites this paper
• Novel Role of the Epstein-Barr Virus Encoded Deubiquitinating Enzyme (BPLF1) in mTOR-Mediated Cell Growth and Proliferation Pathways

  2025cites this paper
• Epstein–Barr Virus Hijacks Redox Signaling via Glutathione Peroxidase 4 to Sustain Latency and Drive Gastric Cancer Progression

  2025cites this paper
• Epstein-Barr Virus Encoded lncRNAs Control the Viral Lytic Switch

  2025cites this paper
• EBV Infection and Its Immune Control in Humanized Mice.

  2025cites this paper
• Gammaherpesvirus infection unveils exaggerated germinal center responses in an SR-BI-deficient host

  2025cites this paper
• CD8+ T cell antitumor immunity via human iNKT-DC conjugates.

  2025cites this paper
• Apolipoprotein E selectively supports gammaherpesvirus replication in macrophages

  2025cites this paper
• Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime

  2025cites this paper
• Epstein–Barr virus pathogenesis and emerging control strategies

  2025cites this paper
• The diagnostic value of soluble Epstein-Barr Virus BZLF1 protein (sZEBRA) in the Detection of Post-transplant lymphoproliferative Disease (PTLD) among Solid Organ (SOT) and Haematopoietic Cell (HSCT) Transplant Recipients.

  2025cites this paper
• Humanized Mouse Systems to Study Viral Infection: A New Era in Immunology Research.

  2025cites this paper
• Epstein-Barr virus and human MiRNAs crosstalk: orchestrating latency, lytic cycle, and immune system modulation.

  2025cites this paper
• Animal models of human herpesvirus infection

  2025cites this paper
• mSphere of Influence: The integral art of resolving host-virus interactions

  2025cites this paper
• Humanized Mouse Models of Epstein Barr Virus Infection

  2025cites this paper
• Human CD4+ iNKT cell adoptive immunotherapy induces anti‐tumour responses against CD1d‐negative EBV‐driven B lymphoma

  2024cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024cites this paper
• Epstein Barr virus: A cellular hijacker in cancer.

  2024cites this paper
• Epigenetic regulation of Epstein–Barr virus: From bench to bedside

  2024cites this paper
• Ubiquitin-Mediated Effects on Oncogenesis during EBV and KSHV Infection

  2024cites this paper
• Epstein-Barr virus lytic replication and cancer.

  2024cites this paper
• Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression

  2024cites this paper
• Altered EBV specific immune control in multiple sclerosis.

  2024cites this paper
• Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression

  2024cites this paper
• Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV).

  2024cites this paper
• Combination of proviral and antiviral roles of B cell-intrinsic STAT1 expression defines parameters of chronic gammaherpesvirus infection

  2024cites this paper
• Precision Meets Repurposing: Innovative Approaches in Human Papillomavirus and Epstein-Barr Virus-Driven Cancer Therapy.

  2024cites this paper
• Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder

  2023cites this paper
• [The incidence of infection in tumor and eye fluid system, and specific humoral immunity to herpes viruses in patients with uveal melanoma].

  2023cites this paper
• Contribution of Epstein–Barr Virus Lytic Proteins to Cancer Hallmarks and Implications from Other Oncoviruses

  2023cites this paper
• Epstein–Barr Virus History and Pathogenesis

  2023cites this paper
• Updated guidelines for chronic active Epstein–Barr virus disease

  2023cites this paper
• Three-Dimensional Chromatin Structure of the EBV Genome: A Crucial Factor in Viral Infection

  2023cites this paper
• An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation

  2023cites this paper
• Interplay between the DNA damage response and the life cycle of DNA tumor viruses

  2023cites this paper
• Microbiota-derived short chain fatty acids: Their role and mechanisms in viral infections

  2023cites this paper
• EBV-induced T-cell responses in EBV-specific and nonspecific cancers

  2023cites this paper
• Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy

  2023cites this paper
• Genotypes Distribution of Epstein–Barr Virus among Lymphoma Patients in Ethiopia

  2023cites this paper
• EBV Reactivation and Lymphomagenesis: More Questions than Answers

  2023cites this paper
• EBV Association with Lymphomas and Carcinomas in the Oral Compartment

  2022cites this paper
• Co-Infection of the Epstein–Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus

  2022cites this paper
• Development of Epstein–Barr virus-associated lymphoproliferative disorder and hemophagocytic lymphohistiocytosis during long-term lenalidomide maintenance therapy in multiple myeloma

  2022cites this paper
• Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription

  2022cites this paper
• High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD

  2022cites this paper
• The roles of DNA methylation on the promotor of the Epstein–Barr virus (EBV) gene and the genome in patients with EBV-associated diseases

  2022cites this paper
• EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non‐endemic region

  2022cites this paper
• Host-directed immunotherapy to fight infectious diseases

  2022cites this paper
• Epstein-Barr virus: Biology and clinical disease.

  2022cites this paper
• Molecular and immune interactions between β‐ and γ‐herpesviruses in the immunocompromised host

  2022cites this paper
• Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine

  2021cites this paper
• Natural Killer Cell Responses during Human γ-Herpesvirus Infections

  2021cites this paper
• Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation

  2021cites this paper
• Modification of EBV-Associated Pathologies and Immune Control by Coinfections

  2021cites this paper
• Antiviral Targeting of the Complex Epstein Barr Virus Life Cycle

  2021cites this paper
• Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1

  2021cites this paper
• Herpesvirus ubiquitin deconjugases.

  2021cites this paper
• EBV+ Lymphoproliferative Diseases: Opportunities for leveraging EBV as a Therapeutic Target.

  2021cites this paper
• Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells

  2021cites this paper
• Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection

  2021cites this paper
• Cancers associated with human gammaherpesviruses

  2021cites this paper
• Immune Escape by Non-coding RNAs of the Epstein Barr Virus

  2021cites this paper
• Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma

  2021cites this paper
• The Role of Coinfections in the EBV–Host Broken Equilibrium

  2021cites this paper
• Epstein-Barr virus: Current questions and challenges

  2021cites this paper
• Defective Epstein-Barr Virus Genomes and Atypical Viral Gene Expression in B-Cell Lines Derived from Multiple Myeloma Patients

  2021cites this paper
• Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice

  2021cites this paper
• Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus

  2021cites this paper
• The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses

  2021cites this paper
• Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3’UTR and Regulates the Lytic Cycle

  2021cites this paper
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!

  2021cites this paper
• Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival

  2021cites this paper
• Regulation of the Macroautophagic Machinery, Cellular Differentiation, and Immune Responses by Human Oncogenic γ-Herpesviruses

  2021cites this paper
• Antiviral Properties of Polyphenols from Plants

  2021cites this paper
• Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas

  2021cites this paper
• Humanized Mouse Models for Evaluation of PSC Immunogenicity.

  2020cites this paper
• Cytotoxicity in Epstein Barr virus specific immune control.

  2020cites this paper
• The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization

  2020cites this paper
• Epstein‐Barr virus may contribute to the pathogenesis of adult‐onset recurrent respiratory papillomatosis: A preliminary study

  2020cites this paper
• Modeling oncogenic herpesvirus infections in humanized mice.

  2020cites this paper
• Oncogenic Properties of the EBV ZEBRA Protein

  2020cites this paper
• EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice

  2020cites this paper
• Redirecting T Cells against Epstein–Barr Virus Infection and Associated Oncogenesis

  2020cites this paper
• Epstein–Barr Virus: How Its Lytic Phase Contributes to Oncogenesis

  2020cites this paper
• Human Papillomaviruses and Epstein–Barr Virus Interactions in Colorectal Cancer: A Brief Review

  2020cites this paper
• Interferon Regulatory Factor 7 Attenuates Chronic Gammaherpesvirus Infection

  2020cites this paper
• Tenofovir prodrugs potently inhibit Epstein–Barr virus lytic DNA replication by targeting the viral DNA polymerase

  2020cites this paper
• Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?

  2020cites this paper
• EBV deletions as biomarkers of response to treatment of Chronic Active Epstein Barr Virus

  2020cites this paper
• The mTOR inhibitor manassantin B reveals a crucial role of mTORC2 signaling in Epstein-Barr virus reactivation

  2020cites this paper
• A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents

  2020cites this paper
• Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections

  2020cites this paper
• Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area

  2020cites this paper
• B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection

  2020cites this paper
• Tumor Microenvironment Conditioning by Abortive Lytic Replication of Oncogenic γ-Herpesviruses.

  2020cites this paper
• An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model

  2020cites this paper
• Animal Models for Gammaherpesvirus Infections: Recent Development in the Analysis of Virus-Induced Pathogenesis

  2020cites this paper
• CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease

  2020influential citation